Brenden Shaw

Brenden Shaw currently serves as Senior Manager at Iovance Biotherapeutics, Inc., overseeing Quality Control in Operations Strategy and External Operations since February 2023. Prior experience includes managerial roles in Quality Control at Merck and Eurofins Lancaster Laboratories, where focus was on sterility and data review in gene therapy. Brenden's background encompasses various quality control positions, including roles at Lannett Company and SPI Pharma, alongside previous experience as a Lead QC Technician at Merck and Data Review Scientist at Charles River Laboratories and Accugenix Inc. Educational credentials include an Executive MBA from Villanova School of Business and a Bachelor of Science in Biology from Ursinus College.